Abstract:HIV-1 causes the loss of CD4+ T cells via depletion or impairment of their production. The latter involves infection of thymocytes, but the involvement of hematopoietic CD34+ cells remains unclear even though HIV-positive patients frequently manifest myelosuppression. In order to have a closer look at the impact of HIV-1 on T-lineage differentiation, this study utilized the OP9-DL1 coculture system, which supports in vitro T-lineage differentiation of human hematopoietic stem/progenitor cells. In the newly dev… Show more
“…These results suggest that the CXCR4-tropic HIV-1 strain may affect the differentiation rate or death rate of CD34 + CD7 + lymphoid progenitor cells, resulting in impaired T-cell production capacity. 33 and HSCs from INRs is much lower than that the colony-forming ability of those from IRs. 39 These studies suggest that incomplete immune reconstitution in HIV-1-infected individuals may be associated with impaired bone marrow hematopoietic function and decreased proliferative capacity.…”
Section: Bone Marrow and Hematopoietic Progenitor Cellsmentioning
confidence: 77%
“…utilized the in vitro OP9‐DL1/HIV‐1 model, cocultured cord‐derived CD34 + HPCs and CXCR4‐tropic HIV‐1 NL4‐3, and showed that CD34 + CD7 + CXCR4 + cells were rapidly depleted 1 week after HIV‐1 infection, accompanied by dramatically diminished numbers of CD34 + CD7 + CD4 + cells. These results suggest that the CXCR4‐tropic HIV‐1 strain may affect the differentiation rate or death rate of CD34 + CD7 + lymphoid progenitor cells, resulting in impaired T‐cell production capacity . Li et al.…”
Section: Potential Mechanisms Of Incomplete Immune Reconstitutionmentioning
The morbidity and mortality of HIV type‐1 (HIV‐1)‐related diseases were dramatically diminished by the grounds of the introduction of potent antiretroviral therapy, which induces persistent suppression of HIV‐1 replication and gradual recovery of CD4+ T‐cell counts. However, ∼10–40% of HIV‐1‐infected individuals fail to achieve normalization of CD4+ T‐cell counts despite persistent virological suppression. These patients are referred to as “inadequate immunological responders,” “immunodiscordant responders,” or “immunological non‐responders (INRs)” who show severe immunological dysfunction. Indeed, INRs are at an increased risk of clinical progression to AIDS and non‐AIDS events and present higher rates of mortality than HIV‐1‐infected individuals with adequate immune reconstitution. To date, the underlying mechanism of incomplete immune reconstitution in HIV‐1‐infected patients has not been fully elucidated. In light of this limitation, it is of substantial practical significance to deeply understand the mechanism of immune reconstitution and design effective individualized treatment strategies. Therefore, in this review, we aim to highlight the mechanism and risk factors of incomplete immune reconstitution and strategies to intervene.
“…These results suggest that the CXCR4-tropic HIV-1 strain may affect the differentiation rate or death rate of CD34 + CD7 + lymphoid progenitor cells, resulting in impaired T-cell production capacity. 33 and HSCs from INRs is much lower than that the colony-forming ability of those from IRs. 39 These studies suggest that incomplete immune reconstitution in HIV-1-infected individuals may be associated with impaired bone marrow hematopoietic function and decreased proliferative capacity.…”
Section: Bone Marrow and Hematopoietic Progenitor Cellsmentioning
confidence: 77%
“…utilized the in vitro OP9‐DL1/HIV‐1 model, cocultured cord‐derived CD34 + HPCs and CXCR4‐tropic HIV‐1 NL4‐3, and showed that CD34 + CD7 + CXCR4 + cells were rapidly depleted 1 week after HIV‐1 infection, accompanied by dramatically diminished numbers of CD34 + CD7 + CD4 + cells. These results suggest that the CXCR4‐tropic HIV‐1 strain may affect the differentiation rate or death rate of CD34 + CD7 + lymphoid progenitor cells, resulting in impaired T‐cell production capacity . Li et al.…”
Section: Potential Mechanisms Of Incomplete Immune Reconstitutionmentioning
The morbidity and mortality of HIV type‐1 (HIV‐1)‐related diseases were dramatically diminished by the grounds of the introduction of potent antiretroviral therapy, which induces persistent suppression of HIV‐1 replication and gradual recovery of CD4+ T‐cell counts. However, ∼10–40% of HIV‐1‐infected individuals fail to achieve normalization of CD4+ T‐cell counts despite persistent virological suppression. These patients are referred to as “inadequate immunological responders,” “immunodiscordant responders,” or “immunological non‐responders (INRs)” who show severe immunological dysfunction. Indeed, INRs are at an increased risk of clinical progression to AIDS and non‐AIDS events and present higher rates of mortality than HIV‐1‐infected individuals with adequate immune reconstitution. To date, the underlying mechanism of incomplete immune reconstitution in HIV‐1‐infected patients has not been fully elucidated. In light of this limitation, it is of substantial practical significance to deeply understand the mechanism of immune reconstitution and design effective individualized treatment strategies. Therefore, in this review, we aim to highlight the mechanism and risk factors of incomplete immune reconstitution and strategies to intervene.
“…Also, in a macaque model, following challenge with simian immunodeficiency virus, BMderived CD34 + cells exhibited reduced T-lineage differentiation potential in vitro without significant changes in phenotypic analysis of CD34 + subsets (Thiebot et al, 2005). Another recent study suggested that CD34 + CD7 + CXCR4 + cells may be depleted in response to CXCR4-tropic HIV-1 infection in a coculture of HIV-infected umbilical cord-derived CD34 + and OP9-DL1 cells (Tsukamoto, 2019b ; Figure 1). Despite the evidence of LPs during HIV-1 infection, our understanding of the impact of HIV-1 on LPs remains limited.…”
Section: The Impact Of Hiv On T-lineage Developmentmentioning
“…[5,40] The majority of studies that have investigated the ability of HIV to infect HSPCs are laboratory-based. [40][41][42]47,48] Due to ethical and logistical challenges related to obtaining sufficient volumes of bone marrow aspirate from HIV-infected individuals, patient (ex vivo)-based studies are scarce. In an isolated study, Redd et al [40] reported that HIV-1 subtype C (HIV-1C), but not HIV-1 subtype B (HIV-1B), has the potential to infect HSCs.…”
Human immunodeficiency virus (HIV) infection not only leads to a compromised immune system, but also disrupts normal haematopoiesis, resulting in the frequent manifestation of cytopenias (anaemia, thrombocytopenia and neutropenia). Although there is a definite association between the severity of cytopenia and HIV disease stage, this relationship is not always linear. For example, cytopenias such as thrombocytopenia may occur during early stages of infection. The aetiology of these haematological abnormalities is complex and multifactorial, including druginduced impaired haematopoiesis, bone marrow suppression due to infiltration of infectious agents or malignant cells, HIV-induced impaired haematopoiesis, and several other factors. In this review, we describe the frequencies of anaemia, thrombocytopenia and neutropenia reported for HIV-infected, treatment-naïve cohorts studied in eastern and southern sub-Saharan African countries. We present a rational approach for the use of diagnostic tests during the workup of HIV-infected patients presenting with cytopenia, and discuss how HIV impacts on haematopoietic stem/progenitor cells (HSPCs) resulting in impaired haematopoiesis. Finally, we describe the direct and indirect effects of HIV on HSPCs which result in defective haematopoiesis leading to cytopenias. S Afr Med J 2019;109(8 Suppl 1):S41-S46. https://doi.org/10.7196/SAMJ.2019.v109i8b.13829 Fig. 1. Schematic illustration of the differentiation of haematopoietic stem/progenitor cells (HSPCs) into mature blood cell types. (MPP = multipotent progenitor; CMP = common myeloid progenitor; CLP = common lymphoid progenitor; MEP = megakaryocyte-erythroid progenitor; GMP = granulocytemacrophage progenitor; NK = natural killer cell.)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.